Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema

Participant Dial-in Details: | |||
United Kingdom | 0800 640 6441 | ||
United Kingdom (Local) | 020 3936 2999 | ||
United States (Local) | 1 646 664 1960 | ||
Netherlands | 085 888 7233 | ||
All other locations | +44 20 3936 2999 |